デフォルト表紙
市場調査レポート
商品コード
1178220

呼吸器用吸入器市場:2023年~2033年

Respiratory Inhalers Market Report 2023-2033

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 354 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=193.91円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

呼吸器用吸入器市場:2023年~2033年
出版日: 2022年12月13日
発行: Visiongain Reports Ltd.
ページ情報: 英文 354 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器用吸入器の市場規模は、2023年に450億米ドルを超えるとみられています。同市場は2033年にかけて、8.02%のCAGRで拡大すると予測されています。

当レポートでは、呼吸器用吸入器 市場について調査し、市場の概要とともに、製品タイプ別、薬剤クラス別、適応症別、操作モード別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
  • COVID-19影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 呼吸器用吸入器市場分析、製品タイプ別

  • 主な調査結果
  • 製品タイプセグメント:市場魅力指数
  • 呼吸器用吸入器市場シェア、製品タイプ別、2023年および2033年
  • 標準定量吸入器(標準pMDI)
  • 加圧定量吸入器(pMDI)
  • スペーサー付き定量吸入器(MDI)
  • ドライパウダー吸入器(DPI)
  • ソフトミスト吸入器
  • その他

第5章 呼吸器用吸入器市場分析、薬剤クラス別

  • 主な調査結果
  • 医薬品クラスセグメント:市場魅力指数
  • 呼吸器用吸入器市場シェア、薬剤クラス別、2023年および2033年
  • 吸入コルチコステロイド(ICS)
  • 短時間作用型ベータ作動薬(SABA)+ 吸入コルチコステロイド(ICS)
  • 短時間作用型ベータ作動薬(SABA)
  • 長時間作用型ベータ作動薬(LABA)
  • 長時間作用型ムスカリン拮抗薬(LAMA)
  • 超長時間作用型Bアゴニスト(ULABA)
  • 短時間作用型ベータ作動薬(SABA)+ 短時間作用型ムスカリン拮抗薬(SAMA)
  • 長時間作用型ベータ作動薬(LABA)+ 長時間作用型ムスカリン拮抗薬(LAMA)+ 吸入コルチコステロイド(ICS)
  • 短時間作用型ムスカリン拮抗薬(SAMA)
  • その他

第6章 呼吸器用吸入器市場分析、適応症別

  • 主な調査結果
  • 適応セグメント:市場魅力指数
  • 呼吸器用吸入器の市場規模の推定と予測、適応症別
  • 喘息
  • 慢性閉塞性肺疾患(COPD)
  • 肺動脈高血圧
  • その他の呼吸器疾患

第7章 呼吸器用吸入器市場分析、操作モード別

  • 主な調査結果
  • オペレーションセグメントのモード:市場魅力指数
  • 呼吸器用吸入器市場シェア、操作モード別、2023年および2033年
  • 手動式吸入器
  • デジタル式吸入器
  • その他の操作モード

第8章 呼吸器用吸入器市場分析、地域別

  • 主な調査結果
  • 市場規模の推定と予測、地域別

第9章 北米の呼吸器用吸入器市場分析

第10章 欧州の呼吸器用吸入器市場分析

第11章 アジア太平洋の呼吸器用吸入器市場分析

第12章 ラテンアメリカの呼吸器用吸入器市場分析

第13章 中等・アフリカの呼吸器用吸入器市場分析

第14章 企業プロファイル

  • Company Share Analysis
  • Strategic Outlook
  • GSK plc
  • Koninklijke Philips N.V.
  • Boehringer Ingelheim International GmbH
  • 3M Health Care
  • AstraZeneca
  • Merck &Co., Inc.
  • Novartis AG
  • OMRON Corporation
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Recipharm AB
  • Medisana GmbH
  • GF Health Products, Inc.
  • AptarGroup, Inc.

第15章 結論と提言

図表

List of Tables

  • Table 1 Respiratory Inhalers Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
  • Table 2 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Table 3 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "U" Shaped Recovery Scenario
  • Table 4 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "W" Shaped Recovery Scenario
  • Table 5 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "L" Shaped Recovery Scenario
  • Table 6 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 7 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 8 MDI with a Spacer Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 9 DPI Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 10 Soft Mist Inhalers Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 11 Other Inhalation Devices Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 12 ICS Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 13 SABA+ICS Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 14 SABA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 15 LABA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 16 LAMA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 17 ULABA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 18 SABA+SAMA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 19 LABA+LAMA+ICS Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 20 SAMA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 21 Others Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 22 Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 23 Cancer Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 24 COPD Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 25 Pulmonary Arterial Hypertension Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 26 Other Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 27 Manually Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 28 Digitally Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 29 Other Mode Of Operation Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 30 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
  • Table 31 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 32 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (Million Units, AGR%, CAGR%)
  • Table 33 North America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 34 North America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 35 North America Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 36 North America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 37 U.S. Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 38 Canada Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 39 Europe Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 40 Europe Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%)
  • Table 41 Europe Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 42 Europe Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 43 Europe Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 44 Europe Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 45 Germany Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 46 UK Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 47 France Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 48 Italy Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 49 Spain Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 50 Russia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 51 Rest of Europe Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 52 Asia Pacific Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 53 Asia Pacific Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%)
  • Table 54 Asia Pacific Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 55 Asia Pacific Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 56 Asia Pacific Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 57 Asia Pacific Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 58 Japan Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 59 China Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 60 India Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 61 Australia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 62 South Korea Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 63 Rest of Asia Pacific Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 64 Latin America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 65 Latin America Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%)
  • Table 66 Latin America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 67 Latin America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 68 Latin America Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 69 Latin America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 70 Brazil Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 71 Mexico Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 72 Argentina Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 73 Rest of Latin America Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 74 MEA Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 75 MEA Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%)
  • Table 76 MEA Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 77 MEA Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 78 MEA Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 79 MEA Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 80 GCC Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 81 South Africa Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 82 Rest of MEA Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 83 Respiratory Drug Delivery Technologies Market Strategic Outlook
  • Table 84 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 GSK plc: Product Benchmarking
  • Table 86 GSK plc: Strategic Outlook
  • Table 87 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Koninklijke Philips N.V.: Product Benchmarking
  • Table 89 Koninklijke Philips N.V.: Strategic Outlook
  • Table 90 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Boehringer Ingelheim International GmbH: Product Benchmarking
  • Table 92 Boehringer Ingelheim International GmbH: Strategic Outlook
  • Table 93 3M Health Care: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 3M Health Care: Product Benchmarking
  • Table 95 3M Health Care: Strategic Outlook
  • Table 96 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 AstraZeneca: Product Benchmarking
  • Table 98 AstraZeneca: Strategic Outlook
  • Table 99 Merck & Co., Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Merck & Co., Inc: Product Benchmarking
  • Table 101 Merck & Co., Inc: Strategic Outlook
  • Table 102 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Novartis AG.: Product Benchmarking
  • Table 104 Novartis AG.: Strategic Outlook
  • Table 105 OMRON Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 OMRON Corporation.: Product Benchmarking
  • Table 107 OMRON Corporation.: Strategic Outlook
  • Table 108 Sunovion Pharmaceuticals Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Sunovion Pharmaceuticals Inc.: Product Benchmarking
  • Table 110 Sunovion Pharmaceuticals Inc.: Strategic Outlook
  • Table 111 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
  • Table 113 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
  • Table 114 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Cipla Inc.: Product Benchmarking
  • Table 116 Cipla Inc.: Strategic Outlook
  • Table 117 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Recipharm AB: Product Benchmarking
  • Table 119 Recipharm AB: Strategic Outlook
  • Table 120 Medisana GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 Medisana GmbH: Product Benchmarking
  • Table 122 GF Health Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 GF Health Products, Inc.: Product Benchmarking
  • Table 124 AptarGroup, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 AptarGroup, Inc.: Product Benchmarking
  • Table 126 AptarGroup, Inc.: Strategic Outlook

List of Figures

  • Figure 1 Respiratory Inhalers Market Segmentation
  • Figure 2 Respiratory Inhalers Market by Indication: Market Attractiveness Index
  • Figure 3 Respiratory Inhalers Market by Mode of Operation: Market Attractiveness Index
  • Figure 4 Respiratory Inhalers Market by Type: Market Attractiveness Index
  • Figure 5 Respiratory Inhalers Market by Drug Class: Market Attractiveness Index
  • Figure 6 Respiratory Inhalers Market Forecast by Region: Market Attractiveness Index
  • Figure 7 Respiratory Inhalers Market: Market Dynamics
  • Figure 8 Product Pipeline Analysis
  • Figure 9 Estimated Geriatric Population by Region in 2020 and by 2050
  • Figure 10 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 11 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 12 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 13 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 14 Respiratory Inhalers Market: Porter's Five Forces Analysis
  • Figure 15 Respiratory Inhalers Market: PESTLE Analysis
  • Figure 16 Respiratory Inhalers Market Forecast by Product Type 2022, 2028, 2033 (Revenue, CAGR%)
  • Figure 17 Respiratory Inhalers Market Share Forecast by Product Type, 2022, 2033 (%)
  • Figure 18 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 19 Standard pMDIs Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 20 pMDIs Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 21 pMDIs Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 MDI with a Spacer Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 23 MDI with a Spacer Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 DPI Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 25 DPI Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 Soft Mist Inhalers Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 27 Soft Mist Inhalers Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Other Inhalation Devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 29 Other Inhalation Devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Respiratory Inhalers Market Forecast by Drug Class 2022, 2028, 2033 (Revenue, CAGR%)
  • Figure 31 Respiratory Inhalers Market Share Forecast by Drug Class, 2022 & 2033 (%)
  • Figure 32 ICS Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 33 ICS Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 SABA+ICS Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 35 SABA+ICS Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 SABA Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 37 SABA Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 LABA Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 39 LABA Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 40 LAMA Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 41 LAMA Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 42 ULABA Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 43 ULABA Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 44 SABA+SAMA Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 45 SABA+SAMA Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 46 LABA+LAMA+ICS Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 47 LABA+LAMA+ICS Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 48 SAMA Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 49 SAMA Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 50 Others Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 51 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 52 Respiratory Inhalers Market Forecast by Indication 2022, 2028, 2033 (Revenue, CAGR%)
  • Figure 53 Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion)
  • Figure 54 Respiratory Inhalers Market Share Forecast by Indication, 2023, 2028, 2033 (%)
  • Figure 55 Asthma Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 56 Asthma Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 57 COPD Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 58 Cardiovascular Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 59 Pulmonary Arterial Hypertension Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 60 Pulmonary Arterial Hypertension Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 61 Other Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 62 Other Respiratory Diseases Market Share Forecast by Region, 2023-2033 (%)
  • Figure 63 Respiratory Inhalers Market Forecast by Mode of Operation 2022, 2028, 2033 (Revenue, CAGR%)
  • Figure 64 Respiratory Inhalers Market Share Forecast by Mode Of Operation, 2022, 2033 (%)
  • Figure 65 Manually Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 66 Cancer Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 67 Digitally Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 68 Digitally Operated Inhaler Devices Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 69 Other Mode Of Operation Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 70 Other Mode Of Operation Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 71 Respiratory Inhalers Market Forecast by Region 2022, 2023, 2028, 2033 (Revenue US$ Bn)
  • Figure 72 Respiratory Inhalers Market Share Forecast by Region 2023, 2028, 2033(%)
  • Figure 73 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
  • Figure 74 North America Respiratory Inhalers Market Attractiveness Index
  • Figure 75 North America Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ billion)
  • Figure 76 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 77 North America Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 78 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (Million Units, AGR %)
  • Figure 79 North America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion)
  • Figure 80 North America Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 81 North America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion)
  • Figure 82 North America Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%)
  • Figure 83 North America Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion)
  • Figure 84 North America Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%)
  • Figure 85 North America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion)
  • Figure 86 North America Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 87 U.S. Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 88 Canada Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 89 Europe Respiratory Inhalers Market Attractiveness Index
  • Figure 90 Europe Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 91 Europe Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 92 Europe Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 93 Europe Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million)
  • Figure 94 Europe Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion)
  • Figure 95 Europe Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 96 Europe Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion)
  • Figure 97 Europe Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%)
  • Figure 98 Europe Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion)
  • Figure 99 Europe Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%)
  • Figure 100 Europe Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion)
  • Figure 101 Europe Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 102 Germany Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 103 UK Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 104 France Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 105 Italy Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 106 Spain Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 107 Russia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 108 Rest of Europe Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 109 Asia Pacific Respiratory Inhalers Market Attractiveness Index
  • Figure 110 Asia Pacific Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 111 Asia Pacific Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 112 Asia Pacific Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 113 Asia Pacific Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million)
  • Figure 114 Asia Pacific Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion)
  • Figure 115 Asia Pacific Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 116 Asia Pacific Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion)
  • Figure 117 Asia Pacific Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%)
  • Figure 118 Asia Pacific Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion)
  • Figure 119 Asia Pacific Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%)
  • Figure 120 Asia Pacific Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion)
  • Figure 121 Asia Pacific Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 122 Japan Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 123 China Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 124 India Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 125 Australia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 126 South Korea Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 127 Rest of Asia Pacific Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 128 Latin America Respiratory Inhalers Market Attractiveness Index
  • Figure 129 Latin America Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 130 Latin America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 131 Latin America Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 132 Latin America Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million, AGR %)
  • Figure 133 Latin America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion)
  • Figure 134 Latin America Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 135 Latin America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion)
  • Figure 136 Latin America Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%)
  • Figure 137 Latin America Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion)
  • Figure 138 Latin America Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%)
  • Figure 139 Latin America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion)
  • Figure 140 Latin America Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%)
  • Figure 141 Brazil Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 142 Mexico Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 143 Argentina Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 144 Rest of Latin America Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 145 MEA Respiratory Inhalers Market Attractiveness Index
  • Figure 146 MEA Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 147 MEA Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion)
  • Figure 148 MEA Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 149 MEA Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million)
  • Figure 150 MEA Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion)
  • Figure 151 MEA Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 152 MEA Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion)
  • Figure 153 MEA Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%)
  • Figure 154 MEA Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion)
  • Figure 155 MEA Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%)
  • Figure 156 GCC Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 157 South Africa Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 158 Rest of MEA Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%)
  • Figure 159 Respiratory Inhalers Market: Company Share Analysis, 2022
  • Figure 160 GSK plc: Net Revenue, 2017-2021 (US$ Million, AGR%)
  • Figure 161 GSK plc: Regional Revenue Shares, 2021
  • Figure 162 GSK: Segmental Revenue Shares, 2021
  • Figure 163 Philips: Net Revenue, 2017-2021 (US$ Million, AGR%)
  • Figure 164 Philips: Regional Revenue Shares, 2021
  • Figure 165 Philips: Segmental Revenue Shares, 2021
  • Figure 166 Boehringer Ingelheim International GmbH: Net Revenue, 2017-2021 (US$ Million, AGR%)
  • Figure 167 Boehringer Ingelheim International GmbH: Regional Revenue Shares, 2021
  • Figure 171 AstraZeneca: Net Revenue, 2017-2021 (US$ billion, AGR%)
  • Figure 172 AstraZeneca: Regional Revenue Shares, 2021
  • Figure 173 AstraZeneca: Segmental Revenue Shares, 2021
  • Figure 174 Merck & Co., Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
  • Figure 175 Merck & Co., Inc.: Regional Revenue Shares, 2021
  • Figure 176 Merck & Co., Inc.: Segmental Revenue Shares, 2021
  • Figure 177 Novartis AG: Net Revenue, 2017-2021 (US$ billion, AGR%)
  • Figure 178 Novartis AG: Regional Revenue Shares, 2021
  • Figure 179 Novartis AG: Segmental Revenue Shares, 2021
  • Figure 183 Sunovion Pharmaceuticals Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
  • Figure 184 Sunovion Pharmaceuticals Inc.: Regional Revenue Shares, 2021
目次
Product Code: PHA1192

The global Respiratory Inhalers market is projected to grow at a CAGR of 8.02% by 2033.

“The Respiratory Inhalers Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing R&D Expenditure by Pharmaceutical and Biotechnology Companies Driving Market Growth

As the demand for greater precision in drug delivery grows, respiratory inhaler devices, particularly among asthmatics and those suffering from chronic obstructive pulmonary disease, are becoming more popular. Because they have a decreased degree of immunity to chronic and pulmonary diseases, an increasing percentage of senior people utilise inhalers. Respiratory inhalers include complementary spacers or holding chambers to reduce the number of debris deposited in the mouth and throat. The market for respiratory products is expected to grow even more in light of the proposed shift to home healthcare.

One of the major digital platforms on which pharma and digital companies collaborate for the management of respiratory diseases is the smart inhaler market. In recent years, government organizations have been concerned about the rising death rates associated with respiratory diseases such as asthma and COPD. Government and regulatory agencies have implemented new guidelines in recent years that will significantly impact the market growth of smart inhalers. Increasing numbers of organizations are integrating digital technologies into their devices in an effort to improve medication management efficiency. The HeroTracker Sense application was launched by Aptar Pharma in April 2023, for example. Pressurized metered dose inhaler (pMDI) can now be converted into a smart connected health device through the use of this new digital respiratory health solution.

High Cost of Inhalers Likely to Challenge Market Growth

Despite the increased prevalence of asthma worldwide, including in emerging markets such as Asia and developed areas such as North America, several barriers to the acceptance of these therapies exist. Inhalers are frequently regarded as the primary treatment for asthma, which is one of the major issues limiting market growth. According to the NCBI study, the CDC will spend approximately 49 billion in 2020, with Medicare covering only 51% of the COPD cost burden. As a result, the price of Advair, a critical asthma medication, has risen to US$648.8 in 2023, up from US$496.0 in 2013.

In addition to the high cost of drugs, underdiagnosis of asthma has been a key issue restricting market expansion. Asthma underdiagnosis leads to lower clinical outcomes for people who are unable to take the right asthma medicines to treat their medical condition. A lack of awareness and perception of asthma in the community, poor access to health care, strained health systems, the absence of diagnostic tests, including spirometry, a lack of training among health care providers, and a lack of non-implementation of asthma guidelines are all factors that contribute to underdiagnosis of asthma.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the respiratory inhalers market evolving?
  • What is driving and restraining the respiratory inhalers market?
  • How will each respiratory inhalers submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each respiratory inhalers submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading respiratory inhalers markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the respiratory inhalers projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of respiratory inhalers projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the respiratory inhalers market?
  • Where is the respiratory inhalers market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the respiratory inhalers market today, and over the next 10 years:

  • Our 354-page report provides 126 tables and 184 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the respiratory inhalers market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising respiratory inhalers prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product Outlook

  • Standard Pressurized Metered-Dose Inhalers
  • Pressurized Metered-dose Inhalers (pMDI)
  • Metered-Dose Inhaler with a Spacer
  • Dry Powder Inhalers
  • Soft Mist Inhalers
  • Other Inhaler Type

Drug Class

  • ICS
  • SABA+ICS
  • SABA
  • LABA
  • LAMA
  • ULABA
  • SABA+SAMA
  • LABA+LAMA+ICS
  • SAMA
  • Other Class

Mode of Operation

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • Other Mode Of Operation

Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Arterial Hypertension (PAH)
  • Others Respiratory Disease

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Respiratory Inhalers Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • 3M Health Care
  • AptarGroup, Inc.
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • GF Health Products, Inc.
  • GSK plc
  • Koninklijke Philips N.V.
  • Medisana GmbH
  • Merck & Co., Inc.
  • Novartis AG
  • OMRON Corporation
  • Recipharm AB
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

Overall world revenue for Respiratory Inhalers Market, 2023 to 2033 in terms of value the market will surpass US$45.0 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Respiratory Inhalers Market, 2023 to 2033 report help you?

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Respiratory Inhalers Market, 2023 to 2033 Market, with forecasts for product type, drug class, mode of operation, and indication, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Respiratory Inhalers Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, LA, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Respiratory Inhalers Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Respiratory Inhalers Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Respiratory Inhalers Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Economic Burden of Asthma and Chronic Respiratory Diseases Will Increase Inhaler Demand
      • 3.2.1.2 Inclusion of Inhalers on the WHO Essential Medicines List (EML) and National Reimbursement Lists (NRL) is a Milestone
      • 3.2.1.3 Asthma as an NCD Priority Driving Demand for Inhalers
      • 3.2.1.4 Increased Demand from Emerging Markets
      • 3.2.1.5 The Pharmaceutical Industry is Embracing Digital Technologies to Combat Asthma
      • 3.2.1.6 Improving Quality of Care Through Innovation
      • 3.2.1.7 Increasing Awareness about Respiratory Drugs and Treatments
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Inhalers Manufacturing Complications is Hindering the Growth
      • 3.2.2.2 Market Growth Could Be Hindered by High Cost of Respiratory Medications
      • 3.2.2.3 Respiratory Disease Research Efforts and Funding Are Not Aligned with the Relative Disability Related to Respiratory Diseases
      • 3.2.2.4 Approval Process for New Respiratory Inhalers and Drugs is Overseen by Various Regulatory Bodies
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Promising R&D Pipeline in the Respiratory Inhalers
      • 3.2.3.2 An aging population that is prone to respiratory conditions is creating opportunities for manufacturers of inhalers
      • 3.2.3.3 Affordable Care Act: Expanding Medicare Coverage
      • 3.2.3.4 Both Innovator and Generic Products Have Met International Standards Creating Revenue Opportunities
    • 3.2.4 Market Challenges
      • 3.2.4.1 Asthma Inhalers Are Among the Most Complex Pharmaceutical Industry Manufactured Medical Devices in Widespread Use
      • 3.2.4.2 Poor Treatment Adherence
      • 3.2.4.3 Low-Income Countries Face Extra Challenges
      • 3.2.4.4 Disruption of Clinical Trials Due to Pandemic Breakout
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis
    • 3.5.1 Political Factors Impacting Respiratory Drug Delivery Technologies Market
    • 3.5.2 Economic Factors Impacting Respiratory Drug Delivery Technologies Market
    • 3.5.3 Social Factors Impacting Respiratory Drug Delivery Technologies Market
    • 3.5.4 Technological Factors Impacting Respiratory Drug Delivery Technologies Market

4 Respiratory Inhalers Market Analysis by Product Type

  • 4.1 Key Findings
  • 4.2 Product Type Segment: Market Attractiveness Index
  • 4.3 Respiratory Inhalers Market Share by Product Type, 2023 & 2033
  • 4.4 Standard Metered-Dose Inhalers (Standard pMDIs)
    • 4.4.1 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ Bn)
    • 4.4.2 Standard pMDIs Market Share by Region, 2023 & 2033 (%)
  • 4.5 Pressurized Metered-dose Inhalers (pMDI)
    • 4.5.1 pMDI Market Forecast by Region, 2023-2033 (US$ Bn)
    • 4.5.2 pMDI Market Share by Region, 2023 & 2033 (%)
  • 4.6 Metered-Dose Inhaler (MDI) with a Spacer
    • 4.6.1 MDI With Spacer Market Forecast by Region, 2023-2033 (US$ Bn)
    • 4.6.2 MDI With Spacer Market Share by Region, 2023 & 2033 (%)
  • 4.7 Dry Powder Inhalers (DPI)
    • 4.7.1 DPI Market Forecast by Region, 2023-2033 (US$ Bn)
    • 4.7.2 DPI Market Share by Region, 2023 & 2033 (%)
  • 4.8 Soft Mist Inhalers
    • 4.8.1 Soft Mist Inhalers Market Forecast by Region, 2023-2033 (US$ Bn)
    • 4.8.2 Soft Mist Inhalers Market Share by Region, 2023 & 2033 (%)
  • 4.9 Other Inhalation Devices
    • 4.9.1 Other Inhalation Devices Market Forecast by Region, 2023-2033 (US$ Bn)
    • 4.9.2 Other Inhalation Devices Market Share by Region, 2023 & 2033 (%)

5 Respiratory Inhalers Market Analysis by Drug Class

  • 5.1 Key Findings
  • 5.2 Drug Class Segment: Market Attractiveness Index
  • 5.3 Respiratory Inhalers Market Share by Drug Class, 2023 & 2033
  • 5.4 Inhaled Corticosteroid (ICS)
    • 5.4.1 ICS Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.4.2 ICS Market Share by Region, 2023 & 2033 (%)
  • 5.5 Short-acting beta-agonists (SABA)+ Inhaled Corticosteroid (ICS)
    • 5.5.1 SABA+ICS Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.5.2 SABA+ICS Market Share by Region, 2023 & 2033 (%)
  • 5.6 Short-acting beta-agonists (SABA)
    • 5.6.1 SABA Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.6.2 SABA Market Share by Region, 2023 & 2033 (%)
  • 5.7 Long-Acting Beta-Agonist (LABA)
    • 5.7.1 LABA Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.7.2 LABA Market Share by Region, 2023 & 2033 (%)
  • 5.8 Long-acting muscarinic antagonists (LAMA)
    • 5.8.1 LAMA Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.8.2 LAMA Market Share by Region, 2023 & 2033 (%)
  • 5.9 Ultra-Long-Acting B-Agonists (ULABA)
    • 5.9.1 ULABA Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.9.2 ULABA Market Share by Region, 2023 & 2033 (%)
  • 5.10 Short-acting beta-agonists (SABA)+ Short-acting muscarinic-antagonist (SAMA)
    • 5.10.1 SABA+SAMA Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.10.2 SABA+SAMA Market Share by Region, 2023 & 2033 (%)
  • 5.11 Long-Acting Beta-Agonist (LABA)+ Long-acting muscarinic antagonists (LAMA) + Inhaled Corticosteroid (ICS)
    • 5.11.1 LABA+LAMA+ICS Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.11.2 LABA+LAMA+ICS Market Share by Region, 2023 & 2033 (%)
  • 5.12 Short-acting muscarinic-antagonist (SAMA)
    • 5.12.1 SAMA Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.12.2 SAMA Market Share by Region, 2023 & 2033 (%)
  • 5.13 Other Class
    • 5.13.1 Others Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.13.2 Others Market Share by Region, 2023 & 2033 (%)

6 Respiratory Inhalers Market Analysis by Indication

  • 6.1 Key Findings
  • 6.2 Indication Segment: Market Attractiveness Index
  • 6.3 Respiratory Inhalers Market Size Estimation and Forecast by Indication
  • 6.4 Asthma
    • 6.4.1 Asthma Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.4.2 Asthma Market Share by Region, 2023-2033 (%)
  • 6.5 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.5.1 COPD Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.5.2 COPD Market Share by Region, 2023 & 2033 (%)
  • 6.6 Pulmonary Arterial Hypertension
    • 6.6.1 Pulmonary Arterial Hypertension Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.6.2 Pulmonary Arterial Hypertension Market Share by Region, 2023 & 2033 (%)
  • 6.7 Other Respiratory Diseases
    • 6.7.1 Other Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.7.2 Other Respiratory Diseases Market Share by Region, 2023-2033 (%)

7 Respiratory Inhalers Market Analysis by Mode of Operation

  • 7.1 Key Findings
  • 7.2 Mode Of Operation Segment: Market Attractiveness Index
  • 7.3 Respiratory Inhalers Market Share by Mode of Operation, 2023 & 2033
  • 7.4 Manually Operated Inhaler Devices
    • 7.4.1 Manually Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ Bn)
    • 7.4.2 Manually Operated Market Share by Region, 2023 & 2033 (%)
  • 7.5 Digitally Operated Inhaler Devices
    • 7.5.1 Digitally Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ Bn)
    • 7.5.2 Digitally Operated Inhaler Devices Market Share by Region, 2023 & 2033 (%)
  • 7.6 Other Mode of Operation
    • 7.6.1 Other Mode of Operation Market Forecast by Region, 2023-2033 (US$ Bn)
    • 7.6.2 Other Mode of Operation Market Share by Region, 2023 & 2033 (%)

8 Respiratory Inhalers Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Respiratory Inhalers Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Respiratory Inhalers Market Attractiveness Index
  • 9.3 North America Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 9.4 North America Respiratory Inhalers Market Size Estimation and Forecast by Country
  • 9.5 North America Respiratory Inhalers Market Volume Estimation and Forecast by Country
  • 9.6 North America Respiratory Inhalers Market Size Estimation and Forecast by Product Type
  • 9.7 North America Respiratory Inhalers Market Size Estimation and Forecast by Drug Class
  • 9.8 North America Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation
  • 9.9 North America Respiratory Inhalers Market Size Estimation and Forecast by Indication
  • 9.10 U.S. Respiratory Inhalers Market Analysis
  • 9.11 Canada Respiratory Inhalers Market Analysis

10 Europe Respiratory Inhalers Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Respiratory Inhalers Market Attractiveness Index
  • 10.3 Europe Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 10.4 Europe Respiratory Inhalers Market Size Estimation and Forecast by Country
  • 10.5 Europe Respiratory Inhalers Market Volume Estimation and Forecast by Country
  • 10.6 Europe Respiratory Inhalers Market Size Estimation and Forecast by Product Type
  • 10.7 Europe Respiratory Inhalers Market Size Estimation and Forecast by Drug Class
  • 10.8 Europe Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation
  • 10.9 Europe Respiratory Inhalers Market Size Estimation and Forecast by Indication
  • 10.10 Germany Respiratory Inhalers Market Analysis
  • 10.11 UK Respiratory Inhalers Market Analysis
  • 10.12 France Respiratory Inhalers Market Analysis
  • 10.13 Italy Respiratory Inhalers Market Analysis
  • 10.14 Spain Respiratory Inhalers Market Analysis
  • 10.15 Russia Respiratory Inhalers Market Analysis
  • 10.16 Rest of Europe Respiratory Inhalers Market Analysis

11 Asia Pacific Respiratory Inhalers Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Respiratory Inhalers Market Attractiveness Index
  • 11.3 Asia Pacific Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 11.4 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Respiratory Inhalers Market Volume Estimation and Forecast by Country
  • 11.6 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Product Type
  • 11.7 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Drug Class
  • 11.8 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation
  • 11.9 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Indication
  • 11.10 Japan Respiratory Inhalers Market Analysis
  • 11.11 China Respiratory Inhalers Market Analysis
  • 11.12 India Respiratory Inhalers Market Analysis
  • 11.13 Australia Respiratory Inhalers Market Analysis
  • 11.14 South Korea Respiratory Inhalers Market Analysis
  • 11.15 Rest of Asia Pacific Respiratory Inhalers Market Analysis

12 Latin America Respiratory Inhalers Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Respiratory Inhalers Market Attractiveness Index
  • 12.3 Latin America Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 12.4 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Country
  • 12.5 Latin America Respiratory Inhalers Market Volume Estimation and Forecast by Country
  • 12.6 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Product Type
  • 12.7 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Drug Class
  • 12.8 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation
  • 12.9 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Indication
  • 12.10 Brazil Respiratory Inhalers Market Analysis
  • 12.11 Mexico Respiratory Inhalers Market Analysis
  • 12.12 Argentina Respiratory Inhalers Market Analysis
  • 12.13 Rest of Latin America Respiratory Inhalers Market Analysis

13 MEA Respiratory Inhalers Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Respiratory Inhalers Market Attractiveness Index
  • 13.3 MEA Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn)
  • 13.4 MEA Respiratory Inhalers Market Size Estimation and Forecast by Country
  • 13.5 MEA Respiratory Inhalers Market Volume Estimation and Forecast by Country
  • 13.6 MEA Respiratory Inhalers Market Size Estimation and Forecast by Product Type
  • 13.7 MEA Respiratory Inhalers Market Size Estimation and Forecast by Drug Class
  • 13.8 MEA Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation
  • 13.9 MEA Respiratory Inhalers Market Size Estimation and Forecast by Indication
  • 13.10 GCC Respiratory Inhalers Market Analysis
  • 13.11 South Africa Respiratory Inhalers Market Analysis
  • 13.12 Rest of MEA Respiratory Inhalers Market Analysis

14 Company Profiles

  • 14.1 Company Share Analysis
  • 14.2 Strategic Outlook
  • 14.1 GSK plc
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
      • 14.1.3.1 Net Revenue, 2017-2020
      • 14.1.3.2 Regional Revenue/Market Shares, 2021
      • 14.1.3.3 Segmental Revenue/Market Shares, 2021
    • 14.1.4 Product Benchmarking
    • 14.1.5 Strategic Outlook
  • 14.2 Koninklijke Philips N.V.
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2017-2021
      • 14.2.3.2 Regional Revenue/Market Shares, 2021
      • 14.2.3.3 Segmental Revenue/Market Shares, 2021
    • 14.2.4 Product Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 Boehringer Ingelheim International GmbH
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2017-2021
      • 14.3.3.2 Regional Revenue/Market Shares, 2021
      • 14.3.3.3 Segmental Revenue/Market Shares, 2021
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 3M Health Care
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2017-2021
      • 10.2.1.1 Regional Revenue/Market Shares, 2021
      • 10.2.1.2 Segmental Revenue/Market Shares, 2021
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 AstraZeneca
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2017-2021
      • 14.5.3.2 Regional Revenue/Market Shares, 2021
      • 14.5.3.3 Segmental Revenue/Market Shares, 2021
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
  • 14.6 Merck & Co., Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2017-2021
      • 14.6.3.2 Regional Revenue/Market Shares, 2021
      • 14.6.3.3 Segmental Revenue/Market Shares, 2021
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Novartis AG
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2017-2021
      • 14.7.3.2 Regional Revenue/Market Shares, 2021
      • 14.7.3.3 Segmental Revenue/Market Shares, 2021
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
  • 14.8 OMRON Corporation
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2017-2021
      • 14.8.3.2 Regional Revenue/Market Shares, 2021
      • 14.8.3.3 Segmental Revenue/Market Shares, 2021
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Sunovion Pharmaceuticals Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2017-2021
      • 14.9.3.2 Regional Revenue/Market Shares, 2021
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 Teva Pharmaceutical Industries Ltd.
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2017-2021
      • 14.10.3.2 Regional Revenue/Market Shares, 2021
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Cipla Inc.
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2017-2021
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Recipharm AB
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2017-2021
      • 14.12.3.2 Regional Revenue/Market Shares, 2021
      • 14.12.3.3 Segmental Revenue/Market Shares, 2021
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 Medisana GmbH
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Product Benchmarking
  • 14.14 GF Health Products, Inc.
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Product Benchmarking
  • 14.15 AptarGroup, Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2017-2021
      • 14.15.3.2 Regional Revenue/Market Shares, 2021
      • 14.15.3.3 Segmental Revenue/Market Shares, 2021
    • 14.15.4 Product Benchmarking
    • 14.15.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players